Sigurdur Olafsson
Chief Executive Officer bei MALLINCKRODT PLC
Vermögen: 5 Mio $ am 31.03.2024
Profil
Sigurdur Oli Olafsson ist ein isländischer Geschäftsmann, der bereits fünf verschiedene Unternehmen geleitet hat und derzeit die Position des Chief Executive Officer & Director bei Hikma Pharmaceuticals Plc innehat. Er ist auch im Vorstand der Amerikanisch-Skandinavischen Stiftung. In der Vergangenheit war Herr Olafsson Chairman bei Elucida Oncology, Inc. und Principal bei Pfizer Inc. und Principal bei Pfizer Ltd. (eine Tochtergesellschaft von Pfizer Inc.), Chief Executive Officer der Actavis Group hf, Chief Executive Officer von Actavis, Inc, President bei Actavis Pharma, Inc, Global Vice President-Investor Relations bei Actavis, Inc, Head-Drug Development bei Omega Farma ehf, Director bei Allergan Plc und President & CEO-Global Generic Medicines bei Teva Pharmaceuticals Ltd. Er erhielt einen Hochschulabschluss von der Universität Island.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2022 | 223 337 ( 0,10% ) | 5 Mio $ | 31.03.2024 |
Aktuelle Nachrichten zu Sigurdur Olafsson
Aktive Positionen von Sigurdur Olafsson
| Unternehmen | Position | Beginn |
|---|---|---|
| MALLINCKRODT PLC | Chief Executive Officer | 25.06.2022 |
The American-Scandinavian Foundation
 The American-Scandinavian Foundation Miscellaneous Commercial ServicesCommercial Services The American-Scandinavian Foundation promotes educational, cultural, and professional exchange between the United States and Scandinavian countries. The non-profit company is based in New York, NY. | Director/Board Member | - |
Ehemalige bekannte Positionen von Sigurdur Olafsson
| Unternehmen | Position | Ende |
|---|---|---|
| HIKMA PHARMACEUTICALS PLC | Chief Executive Officer | 24.05.2022 |
| PFENEX INC. | Director/Board Member | 05.08.2019 |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Chairman | 25.04.2018 |
| Oculis ehf | Chairman | 01.01.2018 |
Teva Pharmaceuticals Ltd.
 Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | President | 01.01.2017 |
Ausbildung von Sigurdur Olafsson
| University of Iceland | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| HIKMA PHARMACEUTICALS PLC | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
Actavis Group hf
 Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Health Technology |
| Omega Farma ehf | Health Technology |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Health Technology |
The American-Scandinavian Foundation
The American-Scandinavian Foundation Miscellaneous Commercial ServicesCommercial Services The American-Scandinavian Foundation promotes educational, cultural, and professional exchange between the United States and Scandinavian countries. The non-profit company is based in New York, NY. | Commercial Services |
Actavis Pharma, Inc.
 Actavis Pharma, Inc. Drugstore ChainsRetail Trade Actavis Pharma, Inc. develops, manufactures, and markets pharmaceutical products. It offers solid dosage and sterile dosage generic products. The company is headquartered in Morristown, NJ. | Retail Trade |
Actavis, Inc. /Old/
 Actavis, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Actavis, Inc. is engaged in developing, manufacturing and sale of generic pharmaceuticals. They provide a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids. The company is located in Morristown, NJ. | Health Technology |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Teva Pharmaceuticals Ltd.
Teva Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom. | Health Technology |
Elucida Oncology, Inc.
Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Health Technology |
| Oculis ehf |
